| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5e7a9f9b6aa26ac3a15dfb7b4c82bc2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-60 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
2003-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad1c170a8a5df16013330cf11ae6cb5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10ebe200d7e6581097cb12698afb6c00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e546045d2e5234b1e828e466733ca1ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_994c1c84e1b599a04a2255467e558a90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1384a7aafcadf6ed791817f23bb5ff33 |
| publicationDate |
2007-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2007037401-A |
| titleOfInvention |
Transcription factor binding substance |
| abstract |
An object of the present invention is to provide a transcription factor-binding substance and a transcription factor control method, and to provide a technique for efficiently amplifying stem cells using them. A transcription factor binding substance is a transcription factor binding substance capable of binding to at least one transcription factor of two or more transcription factors capable of forming a complex related to transcription, and forms a complex related to transcription. And capable of inhibiting at least one binding between two or more possible transcription factors. The two or more transcription factors can include a HOX family protein and PBX1. The transcription factor binding substance can be a peptide having a nuclear translocation signal. This transcription factor binding substance can be used to control transcription factors. Stem cells can also be amplified using this transcription factor binding substance. The stem cell can be a hematopoietic stem cell. [Selection] Figure 2 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009113595-A1 |
| priorityDate |
2003-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |